Position Statement on Cox-2 Inhibitors

skip to: page content | links on this page | site navigation | footer (site information)

ORA Prints

Introduction Principles of Action Patient's Bill of Rights ORA Position Statement on Biologics ORA Position Statement on Cox-2 Inhibitors ORA Position Statement on Teriparatide (Forteo)

Cox-2 Related Links:

U.S. Food and Drug Administration American College of Rheumatology

Position Statement on Selective Cox-2 Inhibitors

The Policy Committee of the Oregon Rheumatology Alliance is currently reviewing our position on Cox-2 Inhibitor policy. For more information, please contact ORA at ora@efn.org

September 30, 2004

Oregon Rheumatology Alliance

ORA Prints

Related Links :

Cox-2 Related Links:

Position Statement on Selective Cox-2 Inhibitors